ASH 2022 Post Conference Perspectives: Innovations in Paroxysmal Nocturnal Hemoglobinuria (PNH)

home / post-conference-perspectives / ash-2022-post-conference-perspectives-innovations-in-paroxysmal-nocturnal-hemoglobinuria-pnh

Carlos M. De Castro, MD, provides updates regarding treatment for paroxysmal nocturnal hemoglobinuria (PNH) from the ASH 2022 Annual Meeting and Exposition.

Episodes

December 21st 2022EP. 1: Phase III Apply-PNH Study Overview

Carlos M. De Castro, MD, highlights the phase III Apply-PNH study presented at ASH 2022.

January 20th 2023EP. 2: Selecting Optimal Treatment Therapies for PNH

Dr De Castro provides an overview of IV versus oral therapies for patients with PNH.

January 27th 2023EP. 3: Biosimilar Integration into PNH Treatment Landscape

Biosimilar products may be utilized as treatment options in PNH.

February 3rd 2023EP. 4: Cost Utilization Analysis in PNH Treatment Pathways

Dr De Castro explores considerations surrounding cost in treatment of PNH.

February 10th 2023EP. 5: Unmet Needs Surrounding PNH

In his closing thoughts, Dr De Castro provides a final overview of the ASH conference, highlighting updates in PNH treatment.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions